AAAAAA

   
Results: 1-8 |
Results: 8
Expression of integrins, degradative enzymes and their inhibitors in uvealmelanoma: differences between in vitro and in vivo expression
Authors: Baker, JKL Elshaw, SR Mathewman, GEL Nichols, CE Murray, AK Parsons, MA Rennie, IG Sisley, K
Citation: Jkl. Baker et al., Expression of integrins, degradative enzymes and their inhibitors in uvealmelanoma: differences between in vitro and in vivo expression, MELANOMA RE, 11(3), 2001, pp. 265-273
Reduced expression of TAP-1 and TAP-2 in posterior uveal melanoma is associated with progression to metastatic disease
Authors: Cresswell, AC Sisley, K Laws, D Parsons, MA Rennie, IG Murray, AK
Citation: Ac. Cresswell et al., Reduced expression of TAP-1 and TAP-2 in posterior uveal melanoma is associated with progression to metastatic disease, MELANOMA RE, 11(3), 2001, pp. 275-281
Cell wall biosynthesis: glycan containing oligomers in developing cotton fibers, cotton fabric, wood and paper
Authors: Murray, AK Nichols, RL Sassenrath-Cole, GF
Citation: Ak. Murray et al., Cell wall biosynthesis: glycan containing oligomers in developing cotton fibers, cotton fabric, wood and paper, PHYTOCHEM, 57(6), 2001, pp. 975-986
A comparison of ocular melanocyte and uveal melanoma cell invasion and theimplication of alpha 1 beta 1, alpha 4 beta 1 and alpha 6 beta 1 integrins
Authors: Elshaw, SR Sisley, K Cross, N Murray, AK MacNeil, SM Wagner, M Nichols, CE Rennie, IG
Citation: Sr. Elshaw et al., A comparison of ocular melanocyte and uveal melanoma cell invasion and theimplication of alpha 1 beta 1, alpha 4 beta 1 and alpha 6 beta 1 integrins, BR J OPHTH, 85(6), 2001, pp. 732-738
Induction of human cytotoxic T lymphocytes that preferentially recognise tumour cells bearing a conformational p53 mutant
Authors: McArdle, SEB Rees, RC Mulcahy, KA Saba, J McIntyre, CA Murray, AK
Citation: Seb. Mcardle et al., Induction of human cytotoxic T lymphocytes that preferentially recognise tumour cells bearing a conformational p53 mutant, CANCER IMMU, 49(8), 2000, pp. 417-425
Oligosaccharides as immunodeterminants of erythropoietin for two sets of anti-carbohydrate antibodies
Authors: Pazur, JH Jensen, PJ Murray, AK
Citation: Jh. Pazur et al., Oligosaccharides as immunodeterminants of erythropoietin for two sets of anti-carbohydrate antibodies, J PROTEIN C, 19(8), 2000, pp. 631-635
Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma
Authors: Palmer, K Moore, J Everard, M Harris, JD Rodgers, S Rees, RC Murray, AK Mascari, R Kirkwood, J Riches, PG Fisher, C Thomas, JM Harries, M Johnston, SRD Collins, MKL Gore, ME
Citation: K. Palmer et al., Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma, HUM GENE TH, 10(8), 1999, pp. 1261-1268
Human antigen-presenting cell/tumour cell hybrids stimulate strong allogeneic responses and present tumour-associated antigens to cytotoxic T cells in vitro
Authors: Dunnion, DJ Cywinski, AL Tucker, VC Murray, AK Rickinson, AB Coulie, P Browning, MJ
Citation: Dj. Dunnion et al., Human antigen-presenting cell/tumour cell hybrids stimulate strong allogeneic responses and present tumour-associated antigens to cytotoxic T cells in vitro, IMMUNOLOGY, 98(4), 1999, pp. 541-550
Risultati: 1-8 |